ClinicalTrials.Veeva

Menu

The Effect of Losartan on the Recoverability of Renal Function in Anuric and Oliguric Patients With Unilateral Obstructed Kidney

M

Mansoura University

Status

Completed

Conditions

Uropathy Obstructive
Uropathy
Losartan Adverse Reaction

Treatments

Drug: Placebo
Drug: Cozaar (Losartan Potassium 25mg)

Study type

Interventional

Funder types

Other

Identifiers

NCT04278495
LOSARTAN.OBST.UROPATHY

Details and patient eligibility

About

Previous experimental studies concluded that angiotensin receptor blockers can ameliorate the harmful inflammatory and histological changes after relief of obstruction. Nevertheless, these witnessed effects have not been yet translated into the clinical practice.

Enrollment

96 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • anuric and oliguric patients
  • calculuar ureteral obstruction

Exclusion criteria

  • anomalous kidney
  • bilateral obstructed kidney
  • history of recent use of angiotensin receptor blockers or angiotensin-converting enzyme inhibitors
  • ASA score of >3

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

96 participants in 2 patient groups, including a placebo group

Losartan
Active Comparator group
Description:
to receive the medication Cozaar (Losartan Potassium 25mg "Merck Sharp \& Dohme-UK"),
Treatment:
Drug: Cozaar (Losartan Potassium 25mg)
Placebo
Placebo Comparator group
Description:
to receive either placebo
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems